Dennis Parenti

2.2k total citations · 1 hit paper
31 papers, 1.5k citations indexed

About

Dennis Parenti is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Dennis Parenti has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 12 papers in Immunology and 10 papers in Hematology. Recurrent topics in Dennis Parenti's work include Rheumatoid Arthritis Research and Therapies (8 papers), Autoimmune and Inflammatory Disorders Research (7 papers) and Vector-borne infectious diseases (6 papers). Dennis Parenti is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Autoimmune and Inflammatory Disorders Research (7 papers) and Vector-borne infectious diseases (6 papers). Dennis Parenti collaborates with scholars based in United States, Belgium and Austria. Dennis Parenti's co-authors include Vijay K. Sikand, Robert T. Schoen, Allen C. Steere, John Nowakowski, Charles Buscarino, François Meurice, David S. Krause, Christopher H. Schmid, Erol Fikrig and Robert Knobler and has published in prestigious journals such as New England Journal of Medicine, Blood and Annals of Internal Medicine.

In The Last Decade

Dennis Parenti

31 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vaccination against Lyme Disease with RecombinantBorrelia burgdorferiOuter-Surface Lipoprotein A with Adjuvant

1998 509 citations Allen C. Steere, Vijay K. Sikand et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dennis Parenti United States	13	653	622	361	352	223	31	1.5k
Rajendranath Ramasawmy Brazil	23	174 0.3×	331 0.5×	328 0.9×	63 0.2×	817 3.7×	71	1.5k
Maria Irma Seixas Duarte Brazil	25	311 0.5×	647 1.0×	276 0.8×	41 0.1×	1.1k 4.9×	124	1.9k
Christine S. Olver United States	16	174 0.3×	117 0.2×	247 0.7×	145 0.4×	190 0.9×	57	1.2k
José F. Camargo United States	24	95 0.1×	780 1.3×	355 1.0×	103 0.3×	99 0.4×	88	1.8k
Adrian V. S. Hill United Kingdom	8	100 0.2×	266 0.4×	608 1.7×	49 0.1×	438 2.0×	8	1.4k
Jan Karel M. Eeftinck Schattenkerk Netherlands	24	248 0.4×	1.3k 2.1×	880 2.4×	63 0.2×	110 0.5×	36	2.8k
Borislava G. Pavlova Austria	17	211 0.3×	368 0.6×	201 0.6×	298 0.8×	230 1.0×	43	1.0k
Richard C. Gehrz United States	23	319 0.5×	277 0.4×	470 1.3×	171 0.5×	78 0.3×	51	1.6k
J. Van Der Veen Netherlands	21	133 0.2×	417 0.7×	212 0.6×	139 0.4×	64 0.3×	59	1.2k
R. B. Heath United Kingdom	22	101 0.2×	421 0.7×	290 0.8×	83 0.2×	76 0.3×	70	1.5k

Countries citing papers authored by Dennis Parenti

Since Specialization

Citations

This map shows the geographic impact of Dennis Parenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Parenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Parenti more than expected).

Fields of papers citing papers by Dennis Parenti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis Parenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Parenti. The network helps show where Dennis Parenti may publish in the future.

Co-authorship network of co-authors of Dennis Parenti

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Parenti. A scholar is included among the top collaborators of Dennis Parenti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Parenti. Dennis Parenti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Curtis, Jeffrey R., Soumya D. Chakravarty, Shawn C. Black, et al.. (2021). Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study. Rheumatology and Therapy. 8(4). 1551–1563. 6 indexed citations

Mease, Philip J., M. Elaine Husni, Soumya D. Chakravarty, et al.. (2020). Evaluation of Improvement in Skin and Nail Psoriasis in Bio‐naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO‐VIBRANT Study. ACR Open Rheumatology. 2(11). 640–647. 9 indexed citations

Cohen, Stanley, Joel M. Kremer, Kimberly J. Dandreo, et al.. (2019). Outcomes of infliximab dose escalation in patients with rheumatoid arthritis. Clinical Rheumatology. 38(9). 2501–2508. 1 indexed citations

Husni, M. Elaine, Philip J. Mease, Soumya D. Chakravarty, et al.. (2019). AB0754 CLINICALLY MEANINGFUL IMPROVEMENT IN SKIN AND NAIL PSORIASIS IN BIO-NAÏVE ACTIVE PSORIATIC ARTHRITIS PATIENTS TREATED WITH INTRAVENOUS GOLIMUMAB: RESULTS THROUGH WEEK 52 FROM A PHASE-3 STUDY. Annals of the Rheumatic Diseases. 78. 1843–1844. 2 indexed citations

Mease, Philip J., M. Elaine Husni, Soumya D. Chakravarty, et al.. (2018). SAT0346 Clinically meaningful improvement in skin and nail psoriasis in bio-naÏve active psoriatic arthritis patients treated with intravenous golimumab: results through week 24 of the go-vibrant study. Annals of the Rheumatic Diseases. 77. 1038–1039. 2 indexed citations

Gaylis, Norman, et al.. (2017). Patient-reported outcome assessment of inflammatory arthritis patient experience with intravenously administered biologic therapy. Patient Preference and Adherence. Volume 11. 1543–1553. 3 indexed citations

Hsia, Elizabeth C., et al.. (2017). SAT0465 An integrated safety data analysis across all phase ii and phase iii clinical programs for ustekinumab in psoriatic arthritis, crohn's disease, and psoriasis. Annals of the Rheumatic Diseases. 76. 950–950. 2 indexed citations

Young, Clarence L., Dennis Parenti, & Marc C. Hochberg. (2014). Lower-dose diclofenac capsules developed using solumatrix fine particle technology result in clinically meaningful improvements in pain in a phase 3 study of patients with osteoarthritis. Osteoarthritis and Cartilage. 22. S399–S399. 2 indexed citations

Reinisch, Walter, Robert Knobler, Paul Rutgeerts, et al.. (2012). Extracorporeal Photopheresis (ECP) in Patients with Steroid-dependent Crohnʼs Disease. Inflammatory Bowel Diseases. 19(2). 293–300. 35 indexed citations

10.

Greinix, Hildegard, Koen van Besien, Ahmet Elmaağaclı, et al.. (2011). Progressive Improvement in Cutaneous and Extracutaneous Chronic Graft-versus-Host Disease after a 24-Week Course of Extracorporeal Photopheresis—Results of a Crossover Randomized Study. Biology of Blood and Marrow Transplantation. 17(12). 1775–1782. 98 indexed citations

11.

Abreu, María T., Christian von Tirpitz, Robert Hardi, et al.. (2009). Extracorporeal photopheresis for the treatment of refractory Crohnʼs disease: Results of an open-label pilot study. Inflammatory Bowel Diseases. 15(6). 829–836. 30 indexed citations

12.

Shaughnessy, Paul, Brian J. Bolwell, Koen van Besien, et al.. (2009). Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 45(6). 1068–1076. 36 indexed citations

13.

Kuffner, Edwin K., Anthony R. Temple, Kimberly Cooper, Jeffrey S. Baggish, & Dennis Parenti. (2006). Retrospective analysis of transient elevations in alanine aminotransferase during long-term treatment with acetaminophen in osteoarthritis clinical trials. Current Medical Research and Opinion. 22(11). 2137–2148. 43 indexed citations

14.

Baine, Yaela, et al.. (2002). Magnitude and quality of antibody response to a combination hepatitis A and hepatitis B vaccine. Antiviral Research. 53(1). 63–73. 12 indexed citations

15.

Blatter, Mark M., Fang Xie, Norbert De Clercq, et al.. (2001). A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix®) with corresponding monovalent vaccines (Havrix® and Engerix-B®) in adults. Vaccine. 19(32). 4710–4719. 81 indexed citations

16.

Sikand, Vijay K., Neal A. Halsey, Peter J. Krause, et al.. (2001). Safety and Immunogenicity of a Recombinant Borrelia burgdorferi Outer Surface Protein A Vaccine Against Lyme Disease in Healthy Children and Adolescents: A Randomized Controlled Trial. PEDIATRICS. 108(1). 123–128. 27 indexed citations

17.

Schoen, Robert T., Vijay K. Sikand, Christian Van Hoecke, et al.. (2000). Safety and immunogenicity profile of a recombinant outer-surface protein a Lyme disease vaccine: Clinical trial of a 3-dose schedule at 0, 1, and 2 months. Clinical Therapeutics. 22(3). 315–325. 20 indexed citations

18.

Hoecke, Christian Van, E. Lebacq, Jiřı́ Beran, & Dennis Parenti. (1999). Alternative Vaccination Schedules (0, 1, and 6 Months Versus 0, 1, and 12 Months) for a Recombinant OspA Lyme Disease Vaccine. Clinical Infectious Diseases. 28(6). 1260–1264. 35 indexed citations

19.

Steere, Allen C., Vijay K. Sikand, François Meurice, et al.. (1998). Vaccination against Lyme Disease with RecombinantBorrelia burgdorferiOuter-Surface Lipoprotein A with Adjuvant. New England Journal of Medicine. 339(4). 209–215. 509 indexed citations breakdown →

20.

Meurice, François, et al.. (1997). Specific Issues in the Design and Implementation of an Efficacy Trial for a Lyme Disease Vaccine. Clinical Infectious Diseases. 25(s1). S71–S75. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact